Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. 2009

Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Stanford University, Stanford, California, USA. smoayeri@yahoo.com

OBJECTIVE To evaluate the cost effectiveness of laparoscopy for unexplained infertility. METHODS We performed a cost-effectiveness analysis using a computer-generated decision analysis tree. Data used to construct the mathematical model were extracted from the literature or obtained from our practice. We compared outcomes following four treatment strategies: [1] no treatment, [2] standard infertility treatment algorithm (SITA), [3] laparoscopy with expectant management (LSC/EM), and [4] laparoscopy with infertility therapy (LSC/IT). The incremental cost-effectiveness ratio (ICER) was calculated, and one-way sensitivity analyses assessed the impact of varying base-case estimates. METHODS Academic in vitro fertilization practice. METHODS Computer-simulated patients assigned to one of four treatments. METHODS Fertility treatment or laparoscopy. METHODS Incremental cost-effectiveness ratios. RESULTS Using base-case assumptions, LSC/EM was preferred (ICER =$128,400 per live-birth in U.S. dollars). Changing the following did not alter results: rates and costs of multiple gestations, penalty for high-order multiples, infertility treatment costs, and endometriosis prevalence. Outcomes were most affected by patient dropout from infertility treatments-SITA was preferred when dropout was less than 9% per cycle. Less important factors included surgical costs, acceptability of twins, and the effects of untreated endometriosis on fecundity. CONCLUSIONS Laparoscopy is cost effective in the initial management of young women with infertility, particularly when infertility treatment dropout rates exceed 9% per cycle.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.

Related Publications

Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
October 2007, The journal of obstetrics and gynaecology research,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
November 2018, Reproductive biomedicine online,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
January 2020, Reproductive biomedicine online,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
July 2012, European journal of obstetrics, gynecology, and reproductive biology,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
January 2012, Clinical and experimental obstetrics & gynecology,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
December 1980, Acta Europaea fertilitatis,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
August 2002, The Journal of reproductive medicine,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
March 2006, Reproductive medicine and biology,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
January 2004, Physiological research,
Sharon E Moayeri, and Henry C Lee, and Ruth B Lathi, and Lynn M Westphal, and Amin A Milki, and Alan M Garber
January 2013, Iranian journal of reproductive medicine,
Copied contents to your clipboard!